Bullish option flow detected in Recursion Pharmaceuticals (RXRX) with 40,958 calls trading, 9x expected, and implied vol increasing over 14 points to 98.01%. 1/24 weekly 8 calls and 1/31 weekly 9 calls are the most active options, with total volume in those strikes near 16,700 contracts. The Put/Call Ratio is 0.05. Earnings are expected on February 27th.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RXRX:
- Unusually active option classes on open January 22nd
- Recursion needs ‘definitive wins’ to validate platform, says JPMorgan
- Recursion Pharmaceuticals Showcases Progress at JP Morgan Conference
- Cathie Wood’s ARK Investment buys 653K shares of Recursion Pharmaceuticals today
- Recursion Pharmaceuticals price target lowered to $10 from $12 at KeyBanc